Financials

Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.7
ratio cours/chiffre d'affaires
21.37

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1014
TWST
Twist Bioscience Corporation - Common Stock
120.60 USD-15.42%-25.27%-42.45%+288.03%7.56 B USD
1149
RDNT
RadNet, Inc. - Common Stock
78.07 USD-2.73%+6.07%+9.54%+0.21%6.14 B USD
1278
BLLN
BillionToOne, Inc. - Class A common stock
112.39 USD-1.32%-0.79%+4.20%+12.39%5.30 B USD
1352
SHC
Sotera Health Company - Common Stock
15.88 USD-3.11%-14.81%-15.40%+0.51%4.54 B USD

Frequently asked questions about GRAIL, Inc. Common Stock

What is the GRAIL, Inc. Common Stock stock price today?

The current price of GRAIL, Inc. Common Stock (GRAL) is 119.40. Over the past 24 hours, the stock has changed by -16.89%. Follow the GRAL chart for real-time price dynamics.

What is the stock ticker of GRAIL, Inc. Common Stock?

GRAIL, Inc. Common Stock trades under the ticker GRAL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is GRAIL, Inc. Common Stock stock going up?

GRAL has changed by -23.51% over the last week, -24.91% over the last month, and +20.61% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of GRAIL, Inc. Common Stock?

GRAIL, Inc. Common Stock currently has a market capitalization of 5.33 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were GRAIL, Inc. Common Stock earnings last quarter?

Last quarter, GRAIL, Inc. Common Stock reported earnings of -2.56 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was GRAIL, Inc. Common Stock revenue for the last quarter?

GRAIL, Inc. Common Stock reported quarterly revenue of 44.69 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was GRAIL, Inc. Common Stock net income for the last quarter?

GRAIL, Inc. Common Stock reported net income of -110.25 M for the last quarter. The previous quarter showed -93.19 M, which means net income changed by -18.31%.

How many employees does GRAIL, Inc. Common Stock have?

As of the latest available data, GRAIL, Inc. Common Stock has 910 employees. Workforce size can provide additional context about the company's scale and operations.

What is GRAIL, Inc. Common Stock EBITDA?

GRAIL, Inc. Common Stock EBITDA is -136.21 M, and its EBITDA margin is -304.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy GRAIL, Inc. Common Stock stock?

You can buy GRAIL, Inc. Common Stock (GRAL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in GRAIL, Inc. Common Stock stock?

Investing in GRAIL, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GRAL chart and related analysis on metatrader.com as part of your research.

GRAIL, Inc. - Common Stock

GRAIL, Inc. est une société américaine de biotechnologie basée à Menlo Park, en Californie, fondée en 2015 dans le but de mettre au point un test de dépistage précoce du cancer destiné aux personnes ne présentant aucun symptôme. À ses débuts, cette start-up était une filiale d’Illumina, qui l’a rachetée intégralement en 2021. En juin 2021, GRAIL a lancé sa biopsie liquide, ou test de dépistage précoce de plusieurs cancers, baptisé « test Galleri ». En 2023, les autorités réglementaires de l’UE ont ordonné la scission de GRAIL d’Illumina, opération qui a été finalisée le 24 juin 2024. Joshua Ofman en est le PDG.